PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND SALTS THEREOF

• 收藏
• 分享

专利权人:

INC.;BETA PHARMA

发明人:

GRECO, Michael,COSTANZO, Michael,GREEN, Michael,PENG, Jirong,WILDE, Victoria,ZHANG, Don

申请号：

SG11201911859Q

公开号：

SG11201911859QA

申请日:

2018.06.15

申请国别(地区):

SG

年份:

2020

代理人:

摘要：

A pharmaceutical formulation of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide (compound 1), in particular methanesulfonic acid salt thereof, and methods of using the pharmaceutical formulation for the treatment or prevention of diseases or medical conditions mediated through mutated forms of epidermal growth factor receptor (EGFR), such as various cancers, are disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/